Related Experiment Video
Updated: Sep 20, 2025

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
CoCliP-BJI study: cost avoidance of clinical pharmacist-led interventions in patients with bone and joint infections
Eloïse Couvé1, Marin Lahouati2, Julie Leitao3
1CHU de Bordeaux, Hôpital Pellegrin, Service de pharmacie clinique, Bordeaux, France.
Objectives:
Patients with bone and joint infections (BJI) are part of a complex care pathway. This study aimed to evaluate the economic impact of clinical pharmacist-led interventions in the management of BJI patients.
Patients And Methods:
We performed a retrospective study documenting all pharmacist-led interventions (PI). Their impact was assessed using the clinical economic and organizational scale (CLEO SFPC). The probability of adverse drug events (ADE) in the absence of PI was assessed by a panel of three experts. Cost avoidance was calculated for PIs with major clinical impact using a cost of €5,331 per event, multiplied by the probability of ADE occurrence.
Results:
A total of 41 PIs had a major clinical impact. Cost avoidance associated with the intervention of a pharmacist was estimated at €83,750.01 during the study.
Conclusion:
The implementation of pharmacist-led interventions in the management of patients with BJI helps avoid preventable healthcare costs.
Related Concept Videos
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Peripheral Artery Disease III: Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Chronic Kidney Disease III: Interprofessional Care
Peripheral Artery Disease IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management

